We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B Turnover 22.5%
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+0.1%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.97B
AUM Growth
-$227M
Cap. Flow
-$120M
Cap. Flow %
-2.42%
Top 10 Hldgs %
24.91%
Holding
802
New
109
Increased
252
Reduced
267
Closed
54
Avg Time Held
1.6 years
Top 10 Avg Time Held
1.1 years
Top 20 Avg Time Held
0.8 years

Top Buys

Rank Stock Value
1
VTR icon
Ventas
VTR
+$29.1M
2
BMY icon
Bristol-Myers Squibb
BMY
+$28.3M
3
ECL icon
Ecolab
ECL
+$25.4M
4
MRK icon
Merck
MRK
+$24.7M
5
EW icon
Edwards Lifesciences
EW
+$20.9M

Top Sells

Rank Stock Value
1
NOW icon
ServiceNow
NOW
+$44M
2
SBAC icon
SBA Communications
SBAC
+$43.3M
3
CMG icon
Chipotle Mexican Grill
CMG
+$42M
4
AMTD icon
TD Ameritrade Holding Corp
AMTD
+$40.5M
5
GILD icon
Gilead Sciences
GILD
+$39.1M

Sector Composition

Rank Sector Weight
1 Healthcare 18.75%
2 Consumer Discretionary 15.42%
3 Technology 15.27%
4 Financials 12.99%
5 Industrials 8.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
CNI icon
151
Canadian National Railway
CNI
$72.9B
$2.67M 0.05%
42,705
-3,700
-8% -$207K
2013 Q2
11 quarters
GIS icon
152
General Mills
GIS
$17.6B
$2.66M 0.05%
41,962
+14
+0% +$814
2013 Q2
11 quarters
MRSH icon
153
Marsh
MRSH
$89B
$2.64M 0.05%
43,427
-1,642
-4% -$92K
2013 Q4
9 quarters
EQNR icon
154
Equinor
EQNR
$106B
$2.64M 0.05%
169,395
-42,940
-20% -$599K
2014 Q2
7 quarters
TSM icon
155
TSMC
TSM
$2.19T
$2.59M 0.05%
98,824
+67,650
+217% +$1.58M
2014 Q1
8 quarters
BMRN icon
156
BioMarin Pharmaceuticals
BMRN
$10.8B
$2.58M 0.05%
31,312
+8,560
+38% +$696K
2013 Q2
11 quarters
IVV icon
157
iShares Core S&P 500 ETF
IVV
$889B
$2.57M 0.05%
12,435
+507
+4% +$99.5K
2013 Q2
11 quarters
DEO icon
158
Diageo
DEO
$52.3B
$2.54M 0.05%
23,563
+2,247
+11% +$238K
2013 Q2
11 quarters
KO icon
159
Coca-Cola
KO
$396B
$2.51M 0.05%
54,110
+18
+0% +$783
2013 Q2
11 quarters
VGK icon
160
Vanguard FTSE Europe ETF
VGK
$29.7B
$2.48M 0.05%
51,144
+148
+0.3% +$6.92K
2015 Q3
2 quarters
WEC icon
161
WEC Energy
WEC
$34.6B
$2.46M 0.05%
41,012
+751
+2% +$42K
2013 Q2
11 quarters
BABA icon
162
Alibaba
BABA
$276B
$2.43M 0.05%
30,775
+1,254
+4% +$88.3K
2014 Q3
6 quarters
CSCO icon
163
Cisco
CSCO
$433B
$2.43M 0.05%
85,323
+7,354
+9% +$189K
2013 Q2
11 quarters
NEOG icon
164
Neogen
NEOG
$2.68B
$2.41M 0.05%
127,621
-51,243
-29% -$976K
2013 Q2
11 quarters
MDY icon
165
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$25.6B
$2.39M 0.05%
9,103
+540
+6% +$131K
2013 Q2
11 quarters
EMC icon
166
DELISTED
EMC CORPORATION
EMC
$2.36M 0.05%
88,418
-10,712
-11% -$271K
2013 Q2
11 quarters
GLD icon
167
SPDR Gold Trust
GLD
$142B
$2.35M 0.05%
20,012
+5,573
+39% +$632K
2013 Q2
11 quarters
GRFS icon
168
Grifois
GRFS
$5.13B
$2.35M 0.05%
151,826
-20,226
-12% -$306K
2013 Q2
11 quarters
TSLA icon
169
Tesla
TSLA
$1.43T
$2.34M 0.05%
152,925
+65,955
+76% +$868K
2013 Q2
11 quarters
RLI icon
170
RLI Corp
RLI
$5.46B
$2.29M 0.05%
68,592
+57,644
+527% +$1.81M
2014 Q4
5 quarters
NVS icon
171
Novartis
NVS
$286B
$2.27M 0.05%
34,907
-292
-0.8% -$19.9K
2013 Q2
11 quarters
CEB
172
DELISTED
CEB Inc.
CEB
$2.25M 0.05%
34,820
-11,851
-25% -$678K
2013 Q2
11 quarters
MJN
173
DELISTED
Mead Johnson Nutrition Company
MJN
$2.25M 0.05%
26,500
-4,830
-15% -$359K
2013 Q2
11 quarters
FMX icon
174
Fomento Económico Mexicano
FMX
$41.2B
$2.2M 0.04%
22,866
+193
+0.9% +$17.6K
2014 Q1
8 quarters
LUX icon
175
DELISTED
Luxottica Group
LUX
$2.18M 0.04%
39,694
-5,772
-13% -$335K
2013 Q2
11 quarters
5 6
7
8 9

Similar funds

CAM
Capstone Asset Management Houston, Texas $3.6B AUM 20.22% 1-Year Est. Return
Virtu KCG Holdings
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
DL
Delta Lloyd Amsterdam, Netherlands $3.56B AUM 18.98% 1-Year Est. Return
Ronald Blue & Co
Ronald Blue & Co Roswell, Georgia $3.1B AUM 12.82% 1-Year Est. Return
TCM
Tetrem Capital Management Winnipeg, Manitoba, Canada $2.29B AUM 16.55% 1-Year Est. Return
HCM
Holland Capital Management Chicago, Illinois $2.28B AUM 23.08% 1-Year Est. Return
AL
Airain Ltd St. Peter Port, Guernsey $2.26B AUM 12.43% 1-Year Est. Return
AT
Alliance Trust Dundee, Scotland, United Kingdom $1.81B AUM 5.04% 1-Year Est. Return

Geneva Advisors's Q1 2016 Portfolio in Review

As of Q1 2016, Geneva Advisors held 802 positions worth $4.97B, down 4.4% from $5.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Geneva Advisors's Q1 2016 filing shows 109 new, 252 increased, 267 reduced and 54 closed positions. Its largest new stake was Ventas: 517,036 shares worth $32.6M. The largest sale was ServiceNow, an estimated $44M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Geneva Advisors's largest Q1 2016 buy was Ventas: 517,036 shares worth $32.6M.
  • Geneva Advisors added most to Bristol-Myers Squibb in Q1 2016, an estimated $28.3M increase.
  • Geneva Advisors's biggest Q1 2016 reduction was SBA Communications, cutting an estimated $43.3M.
  • Geneva Advisors fully exited ServiceNow in Q1 2016, selling an estimated $44M.
  • Geneva Advisors's ten largest holdings make up 25% of its $4.97B portfolio in Q1 2016.
  • Geneva Advisors opened 109 new positions and closed 54 in Q1 2016.
  • Geneva Advisors's portfolio value fell 4.4% quarter-over-quarter to $4.97B.

Based on Geneva Advisors's 13F filing for Q1 2016, filed 3 May 2016.